Gene therapy for erectile dysfunction: What is the future?

Arnold Melman, Kelvin Davies

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Gene transfer for the treatment of erectile dysfunction has completed phase 1 safety testing and has shown the necessary safety to proceed to the next level of clinical trial. This review focuses on the background of the components of that have led to US Food and Drug Administration acceptance of human gene transfer trials for nonlethal disease.

Original languageEnglish (US)
Pages (from-to)421-426
Number of pages6
JournalCurrent urology reports
Volume11
Issue number6
DOIs
Publication statusPublished - Nov 1 2010

    Fingerprint

Keywords

  • Corpora cavernous
  • Erectile dysfunction
  • Gene transfer
  • Naked DNA, Overactive bladder
  • Phase I trial
  • Plasmid
  • Smooth muscle

ASJC Scopus subject areas

  • Urology

Cite this